论文部分内容阅读
《Oncology Tirues》1983;5(11):13。巴塞罗那消息:据国际血液学会会议的一篇报告称,在骨髓移植中使用环孢霉素A,曾并发一定程度的移植物抗宿主病(GVHD)的发生率高于其它一些组。伦敦皇家医学研究生院和Hammersmith医院的高级讲师John M Goldman说,他对慢性粒细胞白血病(CGL)患者发生移植物抗宿主(GVH)的数量感到失望。第一批19例病人中有4例死亡,3例肺栓塞,一例巨细胞病毒感染,当时16人患急性GVHD;有10名是慢性形式。15人平均存活
Oncology Tirues 1983; 5 (11): 13. BARCELONA: According to a report from the International Society of Hematology, the use of cyclosporin A in bone marrow transplantation has had a higher incidence of graft versus host disease (GVHD) than in some other groups. John M Goldman, a senior lecturer at the Royal College of Medicine London and Hammersmith Hospital, said he is disappointed with the number of graft versus host (GVH) patients with chronic myeloid leukemia (CGL). Of the first 19 patients, 4 were fatal, 3 were pulmonary embolism, and one was cytomegalovirus, when 16 were acute GVHD; 10 were chronic. 15 people survived on average